Compound Library

348+ Compounds. Zero Bro-Science.

Evidence-based profiles across healing peptides, GH secretagogues, GLP-1s, SARMs, steroids, nootropics, supplements, PCT ancillaries, and longevity compounds — with pharmacokinetics, dosing protocols, and outcome data.

Search compounds

Search the compound library by name or alias.

25 of 348 compounds match

Risk is a heuristic, not a medical safety rating. Low does not mean safe.

How these filters work

Risk uses the same estimate as compound profiles: legal status, suppression, ancillary requirements, and anabolic rating. Missing data can fall back to Low.

Routes match any documented option, including experimental or formulation-specific routes. Read each result’s qualifications; matching a route is not a recommendation. Missing or unrecognized routes appear only under All routes.

Goals match an editorial score of at least 6/10 for that dimension, including compounds that qualify for several goals. Missing scores do not match a selected goal. These scores do not measure clinical evidence.

Require PCT shows compounds marked as requiring post-cycle therapy. When off, all compounds are included; an unmarked record does not establish that PCT is unnecessary.

Metabolic Peptides

25

GLP-1/GIP/glucagon agonists, mitochondrial peptides, and metabolic regulators engineered for fat loss, insulin sensitivity, and substrate flexibility.

HGH Fragment 176-191
HGH Fragment 176-191 (sold clinically as AOD-9604) is the C-terminal lipolytic tail of human growth hormone — the fat-burning signal without the IGF-1, the wate
Fat Loss 4/108–16wk

Documented routes: SubQ

Insulin
Insulin is the most anabolic hormone in the human body — and in the bodybuilding and looksmaxxing community, it's used not for glucose control but as a post-wor
Muscle 7/104–8wk

Documented routes: SubQ

Retatrutide
Why Retatrutide Is the Most Talked-About Fat Loss Compound of the Decade Retatrutide is the first triple agonist to hit the grey market — a single peptide tha
Fat Loss 10/1012–24wk

Documented routes: SubQ

Semaglutide
Why Semaglutide Became the Cutting Tool Semaglutide rewrote what a cut looks like. A once-weekly shot that quiets "food noise," crushes appetite, and produces
Fat Loss 9/1012–68wk

Documented routes: SubQ, Oral (Rybelsus)

Tirzepatide
Tirzepatide is the most effective fat-loss pharmaceutical ever brought to market, and the physique community figured that out roughly ten minutes after the SURM
Fat Loss 10/108–24wk

Documented routes: SubQ

AOD-9604
AOD-9604 occupies a specific niche in the fat-loss toolkit: it's the lipolytic tail of human growth hormone — residues 176–191 with an added N-terminal tyrosine
Fat Loss 4/108–16wk

Documented routes: SubQ, Oral (low bioavailability)

5-Amino-1MQ
Most fat-loss compounds in this space work by hammering appetite (GLP-1s), cranking the CNS (stimulants), or uncoupling mitochondria outright (DNP). 5-Amino-1MQ
Fat Loss 5/108–12wk

Documented routes: Oral

SLU-PP-332
SLU-PP-332 is the first small molecule to credibly deliver on the "exercise in a vial" promise — a pan-ERR agonist that switches on the same mitochondrial and f
Endurance 8/104–12wk

Documented routes: SubQ, IP (preclinical)

MOTS-c
Why MOTS-c Earned Its Spot in the Stack MOTS-c is one of the more interesting peptides to come out of the last decade of mitochondrial biology — a 16-amino-ac
Endurance 7/104–6wk

Documented routes: SubQ, IP (research)

L-Carnitine
L-carnitine has quietly become one of the most useful adjuncts in the cutting and recomp toolkit — not because it's flashy, but because it does one thing almost
Endurance 5/108–16wk

Documented routes: Oral, IM, SubQ, IV

Cagrilintide
Why Cagrilintide Earned Its Reputation Cagrilintide is a long-acting amylin analog that hits appetite through a completely different pathway than the GLP-1s e
Fat Loss 8/1012–32wk

Documented routes: SubQ

CagriSema
Blend
Why CagriSema Is Worth Paying Attention To CagriSema is the first peptide combo that has credibly out-performed semaglutide monotherapy in a head-to-head phas
Fat Loss 10/1016–68wk

Documented routes: SubQ